KLA Corporation vs NVIDIA Corporation — Stock Comparison
Q·Score Breakdown
7.6
Buy
Overall
9.1
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
KLAC
High-quality business with 101% return on equity and 36% profit margins.
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
Analyst Consensus
BUY
Target $1728.59 (-0.7%)
29 analysts
BUY
Target $269.17 (+33.8%)
57 analysts
Fundamentals
KLAC
NVDA
49.4×
Trailing P/E
41.0×
36.1×
Forward P/E
17.9×
35.8%
Profit Margin
55.6%
61.6%
Gross Margin
71.1%
100.7%
ROE
101.5%
7.2%
Revenue Growth
73.2%
40.9%
Earnings Growth
95.6%
1.44
Beta
2.33
—
Price / Book
—
$228.6B
Market Cap
$4.89T
$675 – $1,939
52-Week Range
$111 – $217
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.